Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Secondary Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation

Stefan Neuburger, MD, Philipp Hemmati, MD, Theis Terwey, MD, Gero Massenkeil, MD, Bernd Dörken, MD, Renate Arnold, MD, PhD

Blood (2008) 112 (11): 4297.

https://doi.org/10.1182/blood.V112.11.4297.4297

Published: 2008

Journal Articles

Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning (RIC) Is Effective for Long-Term Disease Control in High-Risk AML Patients in First Complete Remission.

Philipp G. Hemmati, MD, Gero Massenkeil, MD, Theis H. Terwey, MD, Stefan Neuburger, MD, Philipp le Coutre, MD, Lam Vuong, MD, Bernd Dorken, MD, Renate Arnold, MD

Blood (2007) 110 (11): 3020.

https://doi.org/10.1182/blood.V110.11.3020.3020

Published: 2007

Journal Articles

Treatment Strategies for Patients with Relapsed Acute Lymphoblastic Leukemia: Allogeneic Stem Cell Transplantation Is Effective without Prior Reinduction Chemotherapy.

Theis H. Terwey, MD, Gero Massenkeil, MD, Ingo Tamm, MD, Christoph Lutz, MD, Philipp Hemmati, MD, Stefan Neuburger, MD, Bernd Dorken, MD, Renate Arnold, MD

Blood (2006) 108 (11): 3004.

https://doi.org/10.1182/blood.V108.11.3004.3004

Published: 2006

Journal Articles

Reduced Intensity Conditioning in Acute Leukemias: Long Term Follow-Up Confirms Sustained Complete Remissions.

Gero Massenkeil, MD, Stefan Neuburger, MD, Ingo Tamm, MD, Christoph Lutz, MD, Marion Nagy, PhD, Philipp Le Coutre, MD, Bernd Doerken, MD, Renate Arnold, MD

Blood (2004) 104 (11): 5147.

https://doi.org/10.1182/blood.V104.11.5147.5147

Published: 2004

Journal Articles

Donor Lymphocyte Infusions to Prevent Relapse in Acute Leukemias after Allogenic Stem Cell Transplantation.

Christoph Lutz, MD, Marion Nagy, PhD, Ingo Tamm, MD, Stefan Neuburger, MD, Bernd Doerken, MD, Renate Arnold, MD, Gero Massenkeil, MD

Blood (2004) 104 (11): 1642.

https://doi.org/10.1182/blood.V104.11.1642.1642

Published: 2004

NARROW

Secondary Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning (RIC) Is Effective for Long-Term Disease Control in High-Risk AML Patients in First Complete Remission.

Treatment Strategies for Patients with Relapsed Acute Lymphoblastic Leukemia: Allogeneic Stem Cell Transplantation Is Effective without Prior Reinduction Chemotherapy.

Reduced Intensity Conditioning in Acute Leukemias: Long Term Follow-Up Confirms Sustained Complete Remissions.

Donor Lymphocyte Infusions to Prevent Relapse in Acute Leukemias after Allogenic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Secondary Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning (RIC) Is Effective for Long-Term Disease Control in High-Risk AML Patients in First Complete Remission.

Treatment Strategies for Patients with Relapsed Acute Lymphoblastic Leukemia: Allogeneic Stem Cell Transplantation Is Effective without Prior Reinduction Chemotherapy.

Reduced Intensity Conditioning in Acute Leukemias: Long Term Follow-Up Confirms Sustained Complete Remissions.

Donor Lymphocyte Infusions to Prevent Relapse in Acute Leukemias after Allogenic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only